-
Stocks in News: Cleveland BioLabs (NASDAQ:CBLI), TriVascular Technologies (NASDAQ:TRIV), Premier (NASDAQ:PINC), Weibo Corporation (NASDAQ:WB), SINA Corporation (NASDAQ:SINA)
On Thursday shares of Cleveland BioLabs, Inc. (NASDAQ:CBLI) closed at $1.99. Company’s sales growth for last 5 years was -23.70%. On May 06, Cleveland BioLabs, Inc. (NASDAQ:CBLI) reported financial results and development progress for the first quarter ended March 31, 2015. Cleveland BioLabs reported a $3.7 million net loss for the first quarter of 2015,…
-
Active Stocks: QuinStreet (NASDAQ:QNST), Cleveland BioLabs (NASDAQ:CBLI), BlackBerry Ltd (NASDAQ:BBRY), The York Water Company (NASDAQ:YORW), Westamerica Bancorp. (NASDAQ:WABC)
On Wednesday shares of QuinStreet, Inc. (NASDAQ:QNST) closed at $5.64. Company’s sales growth for last 5 years was 1.60% and EPS growth for next 5 years is recorded as 15.00%. On April 23, 2015, the board of directors (the “Board”) of QuinStreet, Inc. (NASDAQ:QNST) appointed Stuart M. Huizinga to serve as a Class I director…
-
5 Stocks Under Wall Street’s Radar: Endurance International Group (NASDAQ:EIGI), Cleveland BioLabs (NASDAQ:CBLI), Diageo plc (NYSE:DEO), EarthLink (NASDAQ:ELNK), CGG SA (NYSE:CGG)
On Tuesday shares of Endurance International Group Holdings, Inc. (NASDAQ:EIGI) closed at $19.54. Company’s EPS growth for next 5 years is recorded as 19.50%. Endurance International Group Holdings, Inc. (NASDAQ:EIGI), reported financial results for its first quarter ended March 31, 2015. GAAP revenue was $177.3 million, an increase of 22 percent compared to $145.7 million…
-
Market Movers: Cleveland BioLabs (NASDAQ:CBLI), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Highwoods Properties Inc. (NYSE:HIW), Citigroup Inc. (NYSE:C), Sprint Corporation (NYSE:S)
On Monday shares of Cleveland BioLabs, Inc. (NASDAQ:CBLI) closed at $3.55. Company’s sales growth for last 5 years was -23.70%. On April 5, Cleveland BioLabs Inc. (NASDAQ:CBLI) announced in a press release the allowance of a US patent application, to issue as US Patent No. 9,006,183, covering composition of matter for CBLB612, an investigational drug…
-
Market Movers: WPX Energy (NYSE:WPX), Perrigo Company plc Ordinary Shares (NYSE:PRGO), Cleveland BioLabs (NASDAQ:CBLI), Rite Aid (NYSE:RAD), RCS Capital (NYSE:RCAP)
On Wednesday shares of WPX Energy, Inc. (NYSE:WPX) closed at $12.31. Company’s sales growth for last 5 years was -1.00%. Announced April 06, Prometheus Energy Group has entered into a master services agreement with WPX Energy, Inc. (NYSE:WPX) to supply LNG plus related equipment and services for WPX’s initiative to utilize natural gas in its…
-
Investors Watch List: Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR-A), ServiceMaster Global Holdings (NYSE:SERV), Synta Pharmaceuticals (NASDAQ:SNTA), Cleveland BioLabs (NASDAQ:CBLI), Enservco (NYSEMKT:ENSV)
On Friday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR-A) closed at $5.67. Zacks upgraded shares of Petroleo Brasileiro Petrobras SA (NYSE:PBR) from an underperform rating to a neutral rating in a report released on Wednesday. Zacks currently has $5.60 price objective on the stock. ServiceMaster Global Holdings, Inc. (NYSE:SERV) in last trading activity fell…
-
Stocks in Focus: Cleveland BioLabs (NASDAQ:CBLI), Optical Cable Corp. (NASDAQ:OCC), SINA Corporation (NASDAQ:SINA), LyondellBasell Industries N.V. (NYSE:LYB)
On Monday shares of Cleveland BioLabs, Inc. (NASDAQ:CBLI) closed at $4.05. Company’s sales growth for last 5 years was 12.60%. Cleveland BioLabs, Inc. (NASDAQ:CBLI) announced that a maximally tolerated dose has been reached and that dosing has been completed in a Phase 1 healthy subject study of CBLB612, an investigational drug in development for mobilization…
-
Investors Are Gambling: Benefitfocus (NASDAQ:BNFT), Neuralstem (NYSEMKT:CUR), Cleveland BioLabs (NASDAQ:CBLI), Bebe Stores (NASDAQ:BEBE), Panhandle Oil and Gas (NYSE:PHX)
On 24 February, Benefitfocus, Inc. (NASDAQ:BNFT) announced Total revenue was $40.2 million, an increase of 33% compared to the fourth quarter of 2013. Software revenue was $36.1 million, an increase of 28% compared to the fourth quarter of 2013. Professional services revenue was $4.1 million, an increase of 107% compared to the fourth quarter of…
-
Notable Stocks in Focus: Cleveland BioLabs (NASDAQ:CBLI), Groupon (NASDAQ:GRPN), Republic Airways Holdings (NASDAQ:RJET), Gilead Sciences Inc. (NASDAQ:GILD), Telecom Italia (NYSE:TI)
Cleveland BioLabs Inc. (NASDAQ:CBLI) is continuing its talks with federal government agencies as it seeks to fund the development of its most advanced drug candidate, entolimod, and eventually to sell it to the U.S. governmnent for their stockpile in the event of a radiological disaster. On Tuesday shares of Cleveland BioLabs, Inc. (NASDAQ:CBLI) closed at…